What you need to know about the newly detected, more contagious COVID-19 variant
January 6, 2021 at 7:48 am
A UW Medicine health worker check in with a patient at a drive-through coronavirus testing site. (UW Photo / Dennis Wise)
In a final parting shot, 2020 delivered this bit of late-breaking bad news: A new variant of COVID-19 has emerged that appears more contagious and last week was confirmed in one man in Colorado and another in California.
The strain known scientifically by letter and number jumbles including SARS-CoV-2 VOC 202012/01, 501Y.V1 or B.1.1.7 was first detected in the United Kingdom in late September. By November it was the most dominant form of the virus among people infected in Southeast England, which includes London.
Myeloid Therapeutics Launches with Over $50 Million in Financing and Two Clinical Trials
Myeloid s cell therapy harnesses the innate capabilities of myeloid lineage cells to fight cancer
Scientific founders include world-renowned cell therapy & cancer experts Ronald Vale, Ph.D. and Siddhartha Mukherjee, M.D., D.Phil.
Co-Founded by Thomas Cahill, M.D., Ph.D., with financing led by Newpath Partners and participation from leading biotech investors
News provided by
Share this article
Share this article
CAMBRIDGE, Mass., Jan. 6, 2021 /PRNewswire/ Myeloid Therapeutics, Inc., a company harnessing and reprogramming myeloid cells for treating cancers, launched today with over $50 million in financing to initiate multiple clinical trials in 2021. The Company combines advanced gene and cell engineering capabilities with substantial biologics knowledge to elucidate and redirect the power of myeloid cells to treat cancers, particularly solid tumors and those that are poorly served by exi
E-Mail
IMAGE: Photomicrographs demonstrating the impact of T lymphocytes (T cells) associated with the intestinal disease necrotizing enterocolitis (NEC) on myelin a fatty material that surrounds and protects nerve cells . view more
Credit: C. Zhou, C. Sodhi and D. J. Hackam, Johns Hopkins Medicine
Physicians have long known that necrotizing enterocolitis (NEC), a potentially lethal inflammatory condition that destroys a premature infant s intestinal lining, is often connected to the development of severe brain injury in those infants who survive. However, the means by which the diseased intestine communicates its devastation to the newborn brain has remained largely unknown.
Britain is putting vulnerable people at risk from mutant variants of the coronavirus by delaying the second dose of the vaccine, according to South Africa s top adviser on immunisations.
South Africa is suffering a sharp spike in cases, driven by a new variant that may reduce the effectiveness of vaccines.
That threat has been underlined by new lab tests showing that antibodies may be at least 10 times less effective against the new variant, which is separate to the mutation that was originally identified in England.
Please use Chrome browser for a more accessible video player Second new COVID variant highly concerning